Indoco Remedies

Indoco Remedies

311.35
-5.80
(-1.83%)
Market Cap
2,872.14 Cr
EPS
-8.46
PE Ratio
126.00
Dividend Yield
0.06 %
Industry
Healthcare
52 Week High
387.55
52 Week Low
190.00
PB Ratio
2.86
Debt to Equity
0.47
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from5 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy+20.00 %
+20.00 %
Hold
Hold+60.00 %
+60.00 %
Sell
Sell+20.00 %
+20.00 %

Company News

View All News
Caret
positive
Indoco Remedies Plans 4-5 New Product Filings, Debt Reduction of Rs 68 Crore3 days ago
Indoco Remedies announced plans to file 4-5 new products in FY26. The company's management expects to repay Rs 68 crore of debt in the remaining nine months of FY26. For its domestic business, the company expects to add at least 25,000 per man in incremental PHY by year end. The company plans to limit capital expenditure going forward, with only Rs 50 crore incremental capex expected this year, focused on ongoing projects at Goa Plant 2 and the API site for Warren Remedies.
negative
Indoco Remedies Reports Q1 Net Loss of 358M Rupees Against Previous Year's Profit4 days ago
Indoco Remedies reported a consolidated net loss of 358 million rupees in Q1 compared to a profit of 26.2 million rupees in the same quarter last year. Revenue increased marginally to 4.4 billion rupees from 4.3 billion rupees year-over-year. EBITDA declined significantly to 103.5 million rupees from 364.5 million rupees, with EBITDA margin dropping to 2.41% from 8.59% in the previous year.
negative
Indoco Remedies Limited reported quarterly results showing revenue from operations of Rs 38,383 lakhs, representing a 12.5% growth compared to the previous quarter's Rs 34,107 lakhs. However, the company recorded a loss before tax of Rs 2,840 lakhs, contrasting with a profit of Rs 1,951 lakhs in the same quarter of the previous year. The net loss for the period was Rs 2,806 lakhs compared to a profit of Rs 1,495 lakhs in the prior year quarter. EBITDA improved to Rs 148 million from Rs 35 million in the previous quarter. The company operates in the pharmaceuticals segment with revenue split between India (Rs 22,256 lakhs) and outside India (Rs 16,127 lakhs). Two subsidiaries, FPP Holding LLC and Warren Remedies Private Limited, reported significant losses and negative net worth, raising going concern uncertainties, though management believes no impairment provision is necessary based on their assessment.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,702.20
#1 4,08,414.80
35.57
#1 54,729.00
12.06
#1 10,980
-18.99
55.97
6,584.00
1,74,784.51
80.22
9,712.00
0.89
2,191
23.05
40.37
1,572.00
1,26,971.67
22.93
28,409.50
7.12
5,291
9.88
70.77
3,622.90
1,21,969.00
63.65
11,539.40
6.99
1,911
19.91
72.46
1,287.40
1,07,442.68
#1 18.77
33,741.20
16.73
5,725
1.26
54.50
2,541.60
1,04,899.14
61.83
12,744.20
19.57
2,007
-10.91
52.39
980.10
98,620.99
21.15
23,511.00
13.82
4,615
-0.19
54.96
1,960.50
89,535.15
27.44
22,909.50
#1 19.94
3,306
#1 112.49
53.75
32,895.00
69,899.58
50.72
6,684.70
10.80
1,414
27.83
42.22
1,127.00
65,456.34
18.86
31,378.10
17.55
3,366
-0.50
47.15

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
9.35 %
Net Income Growth
-31.83 %
Cash Flow Change
-12.37 %
ROE
-36.80 %
ROCE
-35.79 %
EBITDA Margin (Avg.)
-19.41 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
213
237
249
250
248
287
284
264
267
324
334
297
382
374
349
401
396
405
412
429
417
478
461
462
425
432
404
386
431
Expenses
206
224
238
224
230
260
255
239
227
268
272
250
300
300
285
329
337
345
337
363
365
410
405
401
384
392
399
391
420
EBITDA
7
13
11
26
18
27
30
25
40
56
62
47
82
74
65
72
60
60
74
66
52
68
56
61
42
40
6
-5
10
Operating Profit %
3 %
5 %
4 %
9 %
7 %
9 %
10 %
9 %
15 %
17 %
18 %
15 %
21 %
19 %
18 %
18 %
15 %
15 %
18 %
15 %
12 %
13 %
12 %
9 %
10 %
9 %
1 %
-2 %
2 %
Depreciation
17
18
18
20
17
18
18
18
19
19
17
19
22
20
19
18
20
16
17
18
20
21
24
26
28
29
29
29
30
Interest
7
5
4
5
6
5
7
8
6
6
6
5
4
3
4
3
4
5
7
9
8
8
10
12
14
18
16
18
26
Profit Before Tax
-12
-10
4
9
-0
10
11
8
24
37
38
34
61
65
51
60
48
67
38
39
34
46
23
33
7
-5
-31
-46
-37
Tax
0
-3
-1
-2
-2
2
2
2
7
11
12
9
22
23
18
19
10
18
10
13
10
11
7
11
5
5
-3
-4
-0
Net Profit
-12
-7
5
12
2
8
9
5
17
26
25
25
40
42
33
41
39
50
28
26
24
35
16
22
2
-10
-28
-41
-36
EPS in ₹
-1.32
-0.81
0.57
1.25
0.20
0.85
0.99
0.58
1.85
2.78
2.75
2.71
4.30
4.52
3.58
4.39
4.19
5.40
3.05
2.80
2.62
3.82
1.69
2.39
0.20
-1.09
-3.08
-4.48
-3.94

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
846
941
1,197
1,238
1,258
1,272
1,315
1,486
1,658
2,145
2,430
Fixed Assets
340
374
440
489
468
590
570
555
678
954
1,296
Current Assets
385
465
572
539
538
563
623
774
814
955
1,001
Capital Work in Progress
63
55
91
136
185
51
68
122
114
125
276
Investments
0
16
0
0
0
0
0
0
3
9
419
Other Assets
443
496
666
614
605
631
677
809
864
1,057
0
Total Liabilities
846
941
1,197
1,238
1,258
1,272
1,315
1,486
1,658
2,145
2,430
Current Liabilities
262
303
390
417
446
459
407
425
425
612
808
Non Current Liabilities
65
61
155
146
152
133
139
157
205
422
604
Total Equity
519
577
651
675
661
680
769
905
1,028
1,111
1,022
Reserve & Surplus
500
558
633
657
642
661
751
886
1,010
1,092
1,004
Share Capital
18
18
18
18
18
18
18
18
18
18
19

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-0
50
-52
12
3
-14
8
-7
4
Investing Activities
-88
-111
-171
-135
-104
-56
-67
-121
-208
-433
Operating Activities
109
112
89
123
132
123
82
174
179
157
Financing Activities
-20
-2
132
-39
-16
-64
-30
-44
23
280

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.74 %
58.74 %
58.72 %
58.75 %
58.75 %
58.80 %
58.90 %
58.90 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.12 %
0.12 %
1.59 %
1.69 %
1.91 %
1.47 %
1.70 %
1.25 %
1.24 %
1.22 %
DIIs
18.88 %
18.80 %
17.22 %
17.23 %
17.64 %
17.52 %
17.33 %
18.07 %
17.29 %
17.78 %
19.56 %
19.41 %
18.67 %
18.24 %
18.90 %
18.75 %
18.96 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
15.92 %
15.92 %
17.32 %
17.87 %
17.87 %
17.23 %
16.85 %
16.74 %
16.48 %
16.84 %
15.24 %
15.33 %
16.29 %
16.30 %
16.07 %
15.99 %
15.79 %
Others
6.52 %
6.59 %
6.78 %
6.21 %
5.80 %
6.57 %
7.13 %
6.39 %
7.42 %
5.04 %
4.77 %
4.62 %
4.81 %
5.01 %
4.99 %
5.12 %
5.14 %
No of Share Holders
21,508
24,518
34,746
37,279
37,863
38,498
38,072
35,713
34,731
36,588
32,600
33,201
34,511
34,416
34,676
34,497
33,129

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1.6 1 0.3 0.3 1.5 2.25 2.25 1.5 0.00
Dividend Yield (%) 0.00 0.75 0.49 0.14 0.1 0.4 0.69 0.68 0.64 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jul 2025 325.90 310.05
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 May 2025 251.12 261.58
21 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Jan 2025 326.65 335.15
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 336.65 319.95
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 365.50 365.50
19 Sept 2024 DIVIDEND Dividend
₹ 1.50 /share
19 Sept 2024 327.55 369.65
19 Sept 2023 DIVIDEND Dividend
₹ 2.25 /share
18 Sept 2023 347.80 356.80
16 Sept 2022 DIVIDEND Dividend
₹ 0.75 /share
14 Sept 2022 331.60 359.35
15 Sept 2022 DIVIDEND Dividend
₹ 1.50 /share
14 Sept 2022 331.60 365.20
21 Sept 2021 DIVIDEND Dividend
₹ 1.50 /share
17 Sept 2021 358.65 473.05

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript20 hours ago
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome4 days ago
Financial Results For The Quarter Ended 30Th June 20254 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On 24Th July 20254 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2025
Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30-06-2025.Jul 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Closure of Trading WindowJun 27, 2025
Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN KYC And Bank Details As Per SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 Dated May 07 2024 And SEBI Circular Bearing Reference No. SEBI/HO/MIRSDJun 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 19, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 13, 2025
Announcement Under Regulation 30 (LODR):- Order For Drop Of Proceeding Under GST Act 2017Jun 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 12, 2025
Order For Drop Of ProceedingJun 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 03, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2025
Appointment Of Secretarial Auditor And Internal Auditor Of The CompanyMay 22, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 22, 2025
Financial Results For The Year Ended 31St March 2025May 22, 2025
Board Meeting Outcome for Financial Results For The Year Ended 31St March 2025 And Recommendation Of A Final DividendMay 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
Board Meeting Intimation for Audited Results & DividendMay 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 28, 2025
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations2015 (Listing Regulations)Mar 27, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 25, 2025
Intimation Of Appointment Of Cost Auditor Of The Company Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 21, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
REVISED DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS) Feb 28, 2025
DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS)Feb 25, 2025
DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS)Feb 25, 2025

Technical Indicators

RSI(14)
Neutral
49.78
ATR(14)
Volatile
14.74
STOCH(9,6)
Neutral
25.29
STOCH RSI(14)
Oversold
11.00
MACD(12,26)
Bearish
-3.70
ADX(14)
Strong Trend
33.34
UO(9)
Bearish
42.14
ROC(12)
Downtrend And Accelerating
-6.45
WillR(14)
Neutral
-64.30